Oxford Immunotec Global Plc (OXFD) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Oxford Immunotec Global Plc  (NASDAQ: OXFD)

Select the Financial Report: Select the Period:


Description of Oxford Immunotec Global Plc's Business Segments


Oxford Immunotec Global plc is a biotechnology company that specializes in the development and commercialization of innovative diagnostic tests and services primarily focused on immune response and infectious disease detection. The company is particularly recognized for its expertise in the field of immunology and its commitment to improving patient care through advanced technology.

Major Segments

1. Infectious Disease Testing
- Tuberculosis (TB) Testing: Oxford Immunotec is widely known for its T-SPOT®.TB test, an ELISPOT-based assay designed to detect latent tuberculosis infection (LTBI) by measuring the immune response to specific TB antigens. This test is particularly valuable in populations at risk of TB, such as healthcare workers, immigrants from high-prevalence regions, and immunocompromised individuals.
- Other Infectious Diseases: In addition to TB, the company is expanding its portfolio to include assays for other infectious diseases, such as Lyme disease and COVID-19. These tests often leverage proprietary technologies that assess the immune response rather than relying solely on the presence of pathogens.

2. Autoimmune Disease Testing
- Immunology Assays: Oxford Immunotec offers products that help in understanding various autoimmune conditions by measuring specific immune responses. These assays play a critical role in diagnosing and managing diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis.

3. Transplant Diagnostics
- T Cell-Dependent Immune Response Testing: The company is also involved in the transplant diagnostics space, providing assays that assess immune responses in patients undergoing organ transplantation. This area is crucial for monitoring graft rejection and ensuring patient safety.

4. Research and Development Services
- Oxford Immunotec collaborates with research institutions and pharmaceutical companies to develop custom assays and solutions that facilitate immunological research. These may include targeted immune profiling and support for clinical trials to evaluate new therapeutics.

Products

1. T-SPOT.TB
- An FDA-approved test designed to identify individuals with latent TB infection. The test measures the immune response to specific TB antigens and provides results within 24 hours.

2. QuantiFERON® Tests
- Although primarily part of a different release by QIAGEN, Oxford Immunotec has been involved in developing tests that can measure immune responses using similar strategies.

3. Research and Development Assays
- The companys portfolio includes a range of research assays tailored for clinical laboratories and pharmaceutical companies to assist in studies related to infectious diseases and immune responses.

Services

1. Laboratory Services
- Oxford Immunotec operates various laboratories that provide diagnostic testing services. These labs are equipped with advanced technology to deliver precise and reliable results in a timely manner.

2. Technical Support and Consultation
- The company offers comprehensive technical support and consultancy services to clients, ensuring they have the resources needed to understand and utilize the diagnostic tests effectively.

3. Education and Training
- Providing training programs and educational resources for healthcare professionals to enhance understanding of immunology and the interpretation of assay results forms a vital part of the companys service offerings.

4. Custom Assay Development
- Oxford Immunotec provides bespoke assay development services targeted at fulfilling specific research needs or addressing emerging diagnostic challenges in infectious diseases and immune response profiling.

Summary

Overall, Oxford Immunotecs integrated approach of offering diagnostic tests, laboratory services, and custom research solutions reflects its commitment to advancing immunology and infectious disease detection. The companys products and services are designed to enhance patient outcomes, support healthcare providers, and facilitate critical research in the field of immunology.




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.